Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA interference (RNAi) is a conserved biological process in which small RNA molecules mediate the sequence-specific suppression of gene expression, primarily by targeting messenger RNA (mRNA) for degradation or translational repression. This mechanism is triggered by double-stranded RNA (dsRNA) and operates in a wide range of organisms. Synthetic siRNAs can be designed to silence virtually any gene with known sequence information, making it an attractive tool for functional genomics studies, targeted knockdown of disease-related genes, and potential therapies.
siRNAs are designed to target and degrade specific mRNA sequences, leading to gene silencing.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA interference (None).